Cohance Lifesciences Key Metrics
BSE: - | NSE: - | ISIN: - | Sector: -457.15 -28.60 (-5.89%)Updated : 13 May 2026
Ratios
| Return on average equity - 5 year average | 23.13 |
| Net Income/employee - trailing 12 month | 14,89,604.00 |
| Revenue/employee - most recent fiscal year | 1,05,79,330.00 |
| Return on investment - most recent fiscal year | 11.34 |
| Return on average assets - most recent fiscal year | 10.02 |
| Receivables turnover - most recent fiscal year | 5.49 |
| Return on investment - trailing 12 month | 0.00 |
| Return on average assets - trailing 12 month | 0.00 |
| Inventory turnover - most recent fiscal year | 1.74 |
| Inventory turnover - trailing 12 month | 0.00 |
| Revenue/employee - trailing 12 month | 1,69,26,160.00 |
| Return on average assets - 5 year average | 18.62 |
| Net Income/employee - most recent fiscal year | 23,38,958.00 |
| Return on average equity - trailing 12 month | 0.00 |
| Receivables turnover - trailing 12 month | 0.00 |
| Asset turnover - most recent fiscal year | 0.45 |
| Asset turnover - trailing 12 month | 0.00 |
| Return on average equity - most recent fiscal year | 14.30 |
| Return on investment - 5 year average | 20.90 |
Cohance Lifesciences Quick Links
Cohance Lifesciences Dividend Cohance Lifesciences Bonus Cohance Lifesciences News Cohance Lifesciences AGM Cohance Lifesciences Rights Cohance Lifesciences Splits Cohance Lifesciences Board Meetings Cohance Lifesciences Shareholdings Cohance Lifesciences Profit Loss Cohance Lifesciences Balance Sheet Cohance Lifesciences Cashflow Cohance Lifesciences Q1 Results Cohance Lifesciences Q2 Results Cohance Lifesciences Q3 Results Cohance Lifesciences Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
4,513.40+204.90(4.76%)
2,600.00+70.55(2.79%)
1,760.30+27.45(1.58%)
1,019.55-72.25 (-6.62%)
954.60-17.95 (-1.85%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.